August 29, 2018

Media

Media & events

news

Lyndra Therapeutics and Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics

July 9, 2019
Lyndra Therapeutics and Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics Gilead will have exclusive rights to Lyndra’s...
Read More
1 2 3 12

publications

  • A pharmaceutical answer to non-adherence: Once weekly oral memantine for Alzheimer’s disease
    A pharmaceutical answer to non-adherence: Once weekly oral memantine for Alzheimer’s disease
1 2 3 5
200px-Elsevier.svg
200px-Elsevier.svg
A pharmaceutical answer to non-adherence: Once weekly oral memantine for Alzheimer’s disease

Rosemary Kanasty, Susan Low, Nupura Bhise, JungYanga, ErickPeeke, MarleneSchwarz, JimWright, BennettCarter, SaumyaMoorthy, TylerGrant, BenDeBenedictis, MeganBishoff, CraigSimsesAndrew M.Bellinger

URL : View Project

events

Lyndra Presents @ BIO International

Join us on Thursday, June 5th, at 5pm when Andrew Bellinger, our CSO, presents our 2019 Company Update at BIO International, Philadelphia Convention Center, Theater 4

2019 BIO International

awards

2019 Xconomy Awards Finalist in Startup Category

We are honored to be named a finalist for the Awards in the category for our work making daily pills a thing of the past.

#XconomyAwards